|
1
|
Hamilton W, Peters TJ, Bankhead C and
Sharp D: Risk of ovarian cancer in women with symptoms in primary
care: Population based case-control study. BMJ. 339:2998–3005.
2009. View Article : Google Scholar
|
|
2
|
Torri V, Harper PG, Colombo N, Sandercock
J and Parmar MK: Paclitaxel and cisplatin in ovarian cancer. J Clin
Oncol. 19:2349–2351. 2000.
|
|
3
|
Dean M: ABC transporters, drug resistance,
and cancer stem cells. J Mammary Gland Biol Neoplasia. 14:3–9.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Clarke MF and Fuller M: Stem cells and
cancer: two faces of eve. Cell. 124:1111–1115. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Alvero AB, Chen R and Fu HH: Molecular
phenotyping of human ovarian cancer stem cells unravel the
mechanisms for repair and chemo-resistance. Cell Cycle. 8:158–166.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Johnstone RW, Ruefli AA and Lowe SW:
Apoptosis: a link between cancer genetics and chemotherapy. Cell.
108:153–164. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Eyler CE and Rich JN: Survival of the
fittest: cancer stem cells in therapeutic resistance and
angiogenesis. J Clin Oncol. 26:2839–2845. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hanahan D and Coussens LM: Accessories to
the crime: functions of cells recruited to the tumor
microenvironment. Cancer Cell. 21:309–322. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Condeelis J and Pollard JW: Macrophages:
obligate partners for tumor cell migration, invasion, and
metastasis. Cell. 124:263–266. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vermeulen L, Felipe De Sousa EM, van der
Heijden M, et al: Wnt activity defines colon cancer stem cells and
is regulated by the microenvironment. Nat Cell Biol. 12:468–476.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu A, Wei J, Kong L-Y, et al: Glioma
cancer stem cells induce immunosuppressive macrophages/microglia.
Neuro Oncol. 12:1113–1125. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sica A and Mantovani A: Macrophage
plasticity and polarization: in vivo veritas. J Clin Invest.
122:787–795. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Murray PJ and Wynn TA: Protective and
pathogenic functions of macrophage subsets. Nat Rev Immunol.
11:723–737. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Friedl P and Wolf K: Tumour-cell invasion
and migration: diversity and escape mechanisms. Nat Rev Cancer.
3:362–374. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Coffelt SB, Hughes R and Lewis CE:
Tumor-associated macrophages: effectors of angiogenesis and tumor
progression. Biochim Biophys Acta. 1796:11–18. 2009.PubMed/NCBI
|
|
17
|
Beyer M and Schultze JL: Regulatory T
cells in cancer. 108:pp. 804–811. 2006
|
|
18
|
Siveen KS and Kuttan G: Role of
macrophages in tumour progression. Immunol Lett. 123:97–102. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lewis CE and Pollard JW: Distinct role of
macrophages in different tumor microenvironments. Cancer Res.
66:605–612. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hu L, McArthur C and Jaffe R: Ovarian
cancer stem-like side-population cells are tumourigenic and
chemoresistant. Br J Cancer. 102:1276–1283. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Spira AI, Marx PA, Patterson BK, Mahoney
J, Koup RA, Wolinsky SM and Ho DD: Cellular targets of infection
and route of viral dissemination after an intravaginal inoculation
of simian immunodeficiency virus into rhesus macaques. J Exp Med.
183:215–225. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tacke RS, Tosello-Trampont A, Nguyen V,
Mullins DW and Hahn YS: Extracellular hepatitis C virus core
protein activates STAT3 in human monocytes/macrophages/dendritic
cells via an IL-6 autocrine pathway. J Biol Chem. 286:10847–10855.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Barboni B, Curini V, Russo V, et al:
Indirect co-culture with tendons or tenocytes can program amniotic
epithelial cells towards stepwise tenogenic differentiation. PLoS
One. 7:e309742012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ohtaki H, Ylostalo JH, Foraker JE, et al:
Stem/progenitor cells from bone marrow decrease neuronal death in
global ischemia by modulation of inflammatory/immune responses.
Proc Natl Acad Sci USA. 105:14638–14643. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative CT method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar
|
|
26
|
Subbaramaiah K, Morris PG, Zhou XK, et al:
Increased levels of COX-2 and prostaglandin E2 contribute to
elevated aromatase expression in inflamed breast tissue of obese
women. Cancer Discov. 2:356–365. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Parazzoli S, Harmon J, Vallerie SN, Zhang
T, Zhou H and Robertson RP: COX-2, not mPGES-1, is the dominant
regulator of IL-1β-induced PGE2 production and subsequent
inhibition of pancreatic islet β-cell function during inflammation.
J Biol Chem. 2:486–495. 2012.
|
|
28
|
Allavena P, Sica A, Solinas G, Porta C and
Mantovani A: The inflammatory micro-environment in tumor
progression: the role of tumor-associated macrophages. Crit Rev
Oncol Hematol. 66:1–9. 2008. View Article : Google Scholar
|
|
29
|
Kim J and Hematti P: Mesenchymal stem
cell-educated macrophages: A novel type of alternatively activated
macrophages. Exp Hematol. 37:1445–1453. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang QZ, Su WR, Shi SH, et al: Human
gingiva-derived mesenchymal stem cells elicit polarization of M2
macrophages and enhance cutaneous wound healing. Stem Cells.
28:1856–1868. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bouhlel M, Derudas B, Rigamonti E, et al:
PPARγ activation primes human monocytes into alternative M2
macrophages with anti-inflammatory properties. Cell Metab.
6:137–143. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Monti P, Leone BE, Marchesi F, et al: The
CC chemokine MCP-1/CCL2 in pancreatic cancer progression regulation
of expression and potential mechanisms of antimalignant activity.
Cancer Res. 63:7451–7461. 2003.PubMed/NCBI
|
|
33
|
Singh B, Berry JA, Shoher A, Ramakrishnan
V and Lucci A: COX-2 overexpression increases motility and invasion
of breast cancer cells. Int J Oncol. 26:1393–1399. 2005.PubMed/NCBI
|
|
34
|
Brown JR and DuBois RN: COX-2: a molecular
target for colorectal cancer prevention. J Clin Oncol.
23:2840–2855. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ferrandina G, Lauriola L, Zannoni G, et
al: Increased cyclooxy-genase-2 (COX-2) expression is associated
with chemotherapy resistance and outcome in ovarian cancer
patients. Ann Oncol. 13:1205–1211. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Roca H, Varsos ZS, Sud S, Craig MJ, Ying C
and Pienta KJ: CCL2 and interleukin-6 promote survival of human
CD11b+ peripheral blood mononuclear cells and induce M2-type
macrophage polarization. J Biol Chem. 284:34342–34354. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Martinez FO, Gordon S, Locati M and
Mantovani A: Transcriptional profiling of the human
monocyte-to-macrophage differentiation and polarization: New
molecules and patterns of gene expression. J Immunol.
177:7303–7311. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ding Y-B, Shi R-H, Tong J-D, et al: PGE2
up-regulates vascular endothelial growth factor expression in MKN28
gastric cancer cells via epidermal growth factor receptor signaling
system. Exp Oncol. 27:108–113. 2005.PubMed/NCBI
|
|
39
|
Dorsam RT and Gutkind JS:
G-protein-coupled receptors and cancer. Nat Rev Cancer. 7:79–94.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sica A, Schioppa T, Mantovani A and
Allavena P: Tumour-associated macrophages are a distinct M2
polarised population promoting tumour progression: potential
targets of anti-cancer therapy. Eur J Cancer. 42:717–727. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Aron-Wisnewsky J, Tordjman J, Poitou C, et
al: Human adipose tissue macrophages: m1 and m2 cell surface
markers in subcutaneous and omental depots and after weight loss. J
Clin Endocrinol Metab. 94:4619–4623. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hagemann T, Wilson J, Burke F, et al:
Ovarian cancer cells polarize macrophages toward a tumor-associated
phenotype. J Immunol. 176:5023–5032. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhu W, Huang L, Li Y, et al: Mesenchymal
stem cell-secreted soluble signaling molecules potentiate tumor
growth. Cell Cycle. 10:3198–3207. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Saraiva M and O’Garra A: The regulation of
IL-10 production by immune cells. Nature Reviews Immunol.
10:170–181. 2010. View Article : Google Scholar
|
|
45
|
Sinha P, Clements VK, Bunt SK, Albelda SM
and Ostrand-Rosenberg S: Cross-talk between myeloid-derived
suppressor cells and macrophages subverts tumor immunity toward a
type 2 response. J Immunol. 179:977–983. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wojnarowicz P, Gambaro K, de Ladurantaye
M, et al: Overexpressing the CCL2 chemokine in an epithelial
ovarian cancer cell line results in latency of in vivo
tumourigenicity. Oncogenesis. 1:27–36. 2012. View Article : Google Scholar
|
|
47
|
Zhang J, Patel L and Pienta KJ: CC
chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis
and metastasis. Cytokine Growth Factor Rev. 21:41–48. 2010.
View Article : Google Scholar :
|
|
48
|
Fujimoto H, Sangai T, Ishii G, et al:
Stromal MCP-1 in mammary tumors induces tumor-associated macrophage
infiltration and contributes to tumor progression. Int J Cancer.
125:1276–1284. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ueno T, Toi M, Saji H, et al: Significance
of macrophage chemoattractant protein-1 in macrophage recruitment,
angio-genesis, and survival in human breast cancer. Clin Cancer
Res. 6:3282–3289. 2000.PubMed/NCBI
|
|
50
|
Greenhough A, Smartt HJ, Moore AE, et al:
The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and
adaptation to the tumour microenvironment. Carcinogenesis.
30:377–386. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Nakanishi Y, Nakatsuji M, Seno H, et al:
COX-2 inhibition alters the phenotype of tumor-associated
macrophages from M2 to M1 in ApcMin/+ mouse polyps. Carcinogenesis.
32:1333–1339. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Whiteside TL: Regulatory T cell subsets in
human cancer: are they regulating for or against tumor progression?
Cancer Immunol Immunother. 63:67–72. 2014. View Article : Google Scholar :
|
|
53
|
Eruslanov E, Daurkin I, Ortiz J, Vieweg J
and Kusmartsev S: Pivotal Advance: Tumor-mediated induction of
myeloid-derived suppressor cells and M2-polarized macrophages by
altering intracellular PGE2 catabolism in myeloid cells. J Leukoc
Biol. 88:839–848. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Heusinkveld M, van Steenwijk PJdV,
Goedemans R, et al: M2 macrophages induced by prostaglandin E2 and
IL-6 from cervical carcinoma are switched to activated M1
macrophages by CD4+ Th1 cells. J Immunol. 187:1157–1165. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhang W, Xu W and Xiong S: Macrophage
differentiation and polarization via phosphatidylinositol
3-kinase/Akt-ERK signaling pathway conferred by serum amyloid P
component. J Immunol. 187:1764–1777. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Lawrence T and Natoli G: Transcriptional
regulation of macrophage polarization: enabling diversity with
identity. Nat Rev Immunol. 11:750–761. 2011. View Article : Google Scholar : PubMed/NCBI
|
